Recent News

• 08.05.2025 - Q2 2025 OraSure Technologies, Inc. Earnings Conference Call
• 08.05.2025 - OraSure Announces Second Quarter 2025 Financial Results
• 08.05.2025 - OraSure Announces Second Quarter 2025 Financial Results
• 08.05.2025 - Anne Messing
• 08.04.2025 - OraSure Appoints Anne Messing as Chief Commercial Officer
• 08.04.2025 - OraSure Appoints Anne Messing as Chief Commercial Officer
• 07.21.2025 - OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th
• 07.21.2025 - OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th
• 07.10.2025 - OraSure Launches Novel Blood Collection Device for Proteomic Research
• 07.10.2025 - OraSure Launches Novel Blood Collection Device for Proteomic Research

Recent Filings

• 08.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.30.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 06.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.29.2025 - EFFECT Notice of Effectiveness
• 05.27.2025 - CORRESP Correspondence
• 05.27.2025 - UPLOAD SEC-generated letter
• 05.20.2025 - S-3 Registration statement under Securities Act of 1933
• 05.20.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors